SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001213900-20-017520
Filing Date
2020-07-15
Accepted
2020-07-15 10:55:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SC 13G ea124204-sc13ga1leviston_inn.htm SC 13G/A 78344
  Complete submission text file 0001213900-20-017520.txt   79996
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Subject) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-88303 | Film No.: 201028505
SIC: 2834 Pharmaceutical Preparations

Mailing Address 708 THIRD AVENUE, 6TH FLOOR NEW YORK NY 10017
Business Address 708 THIRD AVENUE, 6TH FLOOR NEW YORK NY 10017 646-317-5070
Leviston Resources LLC (Filed by) CIK: 0001731368 (see all company filings)

IRS No.: 821092151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A